Inventor · disambiguated record
Mark Welch
Also filed as: WELCH MARK · WELCH MARK D
36 granted patents·18 pending applications·3,656 citations·filing 1999–2024
98Inventor score
Top patents by PatentIndex Score
54 records- 0199US8029988B2Oligonucleotide mediated nucleic acid recombinationCODEXIS MAYFLOWER HOLDINGS LLC·Filed 2007·Granted Oct 4, 2011·98 cites·24 claims
- 0299US6521453B1Oligonucloetide mediated nucleic acid recombinationMAXYGEN INC·Filed 2000·Granted Feb 18, 2003·323 cites·24 claims
- 0399US6479652B1Oligonucleotide mediated nucleic acid recombinationMAXYGEN INC·Filed 2000·Granted Nov 12, 2002·247 cites·94 claims
- 0499US6426224B1Oligonucleotide mediated nucleic acid recombinationMAXYGEN INC·Filed 2000·Granted Jul 30, 2002·279 cites·39 claims
- 0599US6423542B1Oligonucleotide mediated nucleic acid recombinationMAXYGEN INC·Filed 2000·Granted Jul 23, 2002·273 cites·7 claims
- 0699US6376246B1Oligonucleotide mediated nucleic acid recombinationMAXYGEN INC·Filed 1999·Granted Apr 23, 2002·584 cites·30 claims
- 0799US6368861B1Oligonucleotide mediated nucleic acid recombinationMAXYGEN INC·Filed 2000·Granted Apr 9, 2002·319 cites·47 claims
- 0899US6319714B1Oligonucleotide mediated nucleic acid recombinationMAXYGEN INC·Filed 2000·Granted Nov 20, 2001·322 cites·7 claims
- 0998US7220566B2Subtilisin variantsMAXYGEN INC·Filed 2003·Granted May 22, 2007·91 cites·8 claims
- 1098US6902922B2Subtilisin variantsMAXYGEN INC·Filed 2001·Granted Jun 7, 2005·116 cites·27 claims
- 1197US9580697B2Enhanced nucleic acid constructs for eukaryotic gene expressionDNA2 0 INC·Filed 2016·Granted Feb 28, 2017·28 cites·8 claims
- 1297US9574209B2Enhanced nucleic acid constructs for eukaryotic gene expressionDNA2 0 INC·Filed 2016·Granted Feb 21, 2017·27 cites·20 claims
- 1397US9534234B2Enhanced nucleic acid constructs for eukaryotic gene expressionDNA2 0 INC·Filed 2015·Granted Jan 3, 2017·25 cites·6 claims
- 1497US9428767B2Enhanced nucleic acid constructs for eukaryotic gene expressionDNA2 0 INC·Filed 2015·Granted Aug 30, 2016·33 cites·18 claims
- 1597US6436675B1Use of codon-varied oligonucleotide synthesis for synthetic shufflingMAXYGEN INC·Filed 1999·Granted Aug 20, 2002·332 cites·39 claims
- 1696US8014961B2Integrated systems and methods for diversity generation and screeningCODEXIS MAYFLOWER HOLDINGS LLC·Filed 2007·Granted Sep 6, 2011·95 cites·15 claims
- 1796US7561972B1Synthetic nucleic acids for expression of encoded proteinsDNA TWOPOINTO INC·Filed 2008·Granted Jul 14, 2009·45 cites·20 claims
- 1896US7561973B1Methods for determining properties that affect an expression property value of polynucleotides in an expression systemDNA TWOPOINTO INC·Filed 2008·Granted Jul 14, 2009·53 cites·20 claims
- 1996US7462469B2Integrated system for diversity generation and screeningMAXYGEN INC·Filed 2002·Granted Dec 9, 2008·94 cites·8 claims
- 2095US8058001B2Oligonucleotide mediated nucleic acid recombinationCRAMERI ANDREAS·Filed 2009·Granted Nov 15, 2011·152 cites·33 claims
- 2194US8401798B2Systems and methods for constructing frequency lookup tables for expression systemsWELCH MARK·Filed 2008·Granted Mar 19, 2013·26 cites·31 claims
- 2294US8126653B2Synthetic nucleic acids for expression of encoded proteinsWELCH MARK·Filed 2008·Granted Feb 28, 2012·30 cites·63 claims
- 2392US10344285B2DNA vectors, transposons and transposases for eukaryotic genome modificationDNA2 0 INC·Filed 2016·Granted Jul 9, 2019·4 cites·22 claims
- 2492US10233454B2DNA vectors, transposons and transposases for eukaryotic genome modificationDNA2 0 INC·Filed 2016·Granted Mar 19, 2019·4 cites·22 claims
- 2591US10927384B2DNA vectors, transposons and transposases for eukaryotic genome modificationDNA TWOPOINTO INC·Filed 2016·Granted Feb 23, 2021·4 cites·20 claims
- 2691US6777218B1Subtilase enzymes having an improved wash performance on egg stainsNOVOZYMES AS·Filed 2000·Granted Aug 17, 2004·34 cites·25 claims
- 2790US2025043235A1Dna vectors, transposons and transposases for eukaryotic genome modificationDNA TWOPOINTO INC·Filed 2024·Application pending·0 cites
- 2887US10480018B2Genus of epimerase enzymes for conversion of fructose to allulose at high temperature and low pHARCHER DANIELS MIDLAND CO·Filed 2016·Granted Nov 19, 2019·4 cites·4 claims
- 2980US2022282260A1Dna vectors, transposons and transposases for eukaryotic genome modificationDNA TWOPOINTO INC·Filed 2022·Application pending·0 cites
- 3077US12435129B2Anti-Aβ antibodiesOTHAIR PROTHENA LTD·Filed 2021·Granted Oct 7, 2025·0 cites·14 claims
- 3177US12122995B2DNA vectors, transposons and transposases for eukaryotic genome modificationDNA2 0 INC·Filed 2019·Granted Oct 22, 2024·0 cites·34 claims
- 3276US12054702B2DNA vectors, transposons and transposases for eukaryotic genome modificationDNA TWOPOINTO INC·Filed 2021·Granted Aug 6, 2024·0 cites·7 claims
- 3376US2025243475A1Methods and compositions for treating congenital sucrase-isomaltase deficiencyANAGRAM THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3475US7507569B2Variant subtilisin enzymes (subtilases)NOVOZYMES AS·Filed 2004·Granted Mar 24, 2009·13 cites·13 claims
- 3573US10443060B2Nucleic acids and vectors for use with methanotrophic bacteriaCALYSTA INC·Filed 2015·Granted Oct 15, 2019·1 cites·24 claims
- 3673US2019323018A1DNA Vectors, Transposons And Transposases For Eukaryotic Genome ModificationDNA2 0 INC·Filed 2019·Application pending·0 cites
- 3771US2019010505A1Dna vectors, transposons and transposases for eukaryotic genome modificationDNA2 0 INC·Filed 2018·Application pending·0 cites
- 3870US2010105599A1Subtilisin variantsNOVOZYMES AS·Filed 2009·Application pending·0 cites
- 3969US2019169622A1DNA Vectors, Transposons And Transposases For Eukaryotic Genome ModificationDNA2 0 INC·Filed 2019·Application pending·0 cites
- 4066US11041159B2Nucleic acids and vectors for regulated target gene expression in methanotrophic bacteriaCALYSTA INC·Filed 2019·Granted Jun 22, 2021·0 cites·15 claims
- 4166US7605115B2Subtilisin variantsNOVOZYMES AS·Filed 2007·Granted Oct 20, 2009·0 cites·10 claims
- 4265US10815461B2Recombinant uricase enzymeALLENA PHARMACEUTICALS INC·Filed 2019·Granted Oct 27, 2020·0 cites·30 claims
- 4365US2013183664A1Systems and methods for constructing frequency lookup tables for expression systemsDAN TWOPOINTO INC·Filed 2012·Application pending·0 cites
- 4463US2024392270A1Engineered lipase enzymes, manufacture and use thereofANAGRAM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4562US11859228B2Epimerase enzymes and their useARCHER DANIELS MIDLAND CO·Filed 2019·Granted Jan 2, 2024·0 cites·8 claims
- 4662US2007054313A1Oligonucleotide mediated nucleic acid recombinationMAXYGEN INC·Filed 2006·Application pending·0 cites
- 4760US2001039014A1Integrated systems and methods for diversity generation and screeningMAXYGEN INC·Filed 2001·Application pending·0 cites
- 4859US2007065838A1Oligonucleotide mediated nucleic acid recombinationMAXYGEN INC·Filed 2006·Application pending·0 cites
- 4958US2012040871A1Oligonucleotide mediated nucleic acid recombinationCRAMERI ANDREAS·Filed 2011·Application pending·0 cites
- 5054US2002102577A1Nucleotide incorporating enzymesFiled 2001·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Mark Welch files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →